High-purity Enfuvirtide Acetate API — GMP Certified
Enfuvirtide Acetate (T-20 Acetate) is the acetate salt of Enfuvirtide, a synthetic 36-amino acid peptide HIV fusion inhibitor used in the treatment of HIV-1 infection in treatment-experienced patients. Mediocon Inc manufactures Enfuvirtide Acetate API to IP/BP/EP/USP standards in its GMP-certified facility in Aurangabad, Maharashtra, India.
Our Enfuvirtide Acetate API is supplied to antiretroviral injectable pharmaceutical manufacturers globally. Full quality documentation including CoA, MSDS, COO, and DMF support is provided.
Key Features
Applications
Why Choose Mediocon
| Parameter | Specification |
|---|---|
| Assay | NLT 98.0% |
| Loss on Drying | NMT 0.5% |
| Heavy Metals | NMT 20 ppm |
| Residue on Ignition | NMT 0.1% |
| Microbial Limits | Complies with pharmacopoeia |
| Identification | IR, HPLC Compliant |
| Packing | 25 kg HDPE drums / as per requirement |
Mediocon Inc is a GMP-certified API manufacturer and bulk pharmaceutical ingredient supplier based in Aurangabad, Maharashtra, India. We specialise in supplying Enfuvirtide Acetate (CAS 159519-65-0) and over 1,000 other Active Pharmaceutical Ingredients, excipients, herbal extracts, and nutraceutical ingredients to pharmaceutical manufacturers worldwide.
Our Enfuvirtide Acetate is manufactured under strict quality management protocols compliant with WHO-GMP, ISO 9001:2015, and major pharmacopoeial standards (IP, BP, USP, EP). Every batch undergoes full analytical testing — identity (IR/HPLC), assay, related substances, residual solvents (ICH Q3C), heavy metals, and microbial limits — before release with a Certificate of Analysis.
Export Markets
Quality & Compliance